GB2415379B - Methyl-ß-orcinolcarboxylate from lichen (everniasrum cirrhatum) for use for the treatment of cancer - Google Patents

Methyl-ß-orcinolcarboxylate from lichen (everniasrum cirrhatum) for use for the treatment of cancer

Info

Publication number
GB2415379B
GB2415379B GB0522200A GB0522200A GB2415379B GB 2415379 B GB2415379 B GB 2415379B GB 0522200 A GB0522200 A GB 0522200A GB 0522200 A GB0522200 A GB 0522200A GB 2415379 B GB2415379 B GB 2415379B
Authority
GB
United Kingdom
Prior art keywords
orcinolcarboxylate
everniasrum
cirrhatum
lichen
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB0522200A
Other versions
GB2415379A (en
GB0522200D0 (en
Inventor
Suman Preet Singh Khanuja
Ranganathan Tiruppadiripuliyur
Vivek Kumar Gupta
Preeti Chand
Ankur Garg
Santosh Kumar Srivastava
Subash Chandra Verma
Dharmendra Saikia
Mahendra Pandurang Darokar
Ajit Kumar Shasany
Anirban Pal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Council of Scientific and Industrial Research CSIR
Original Assignee
Council of Scientific and Industrial Research CSIR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council of Scientific and Industrial Research CSIR filed Critical Council of Scientific and Industrial Research CSIR
Priority to GB0701454A priority Critical patent/GB2432530A/en
Priority to GB0716892A priority patent/GB2438552B/en
Publication of GB0522200D0 publication Critical patent/GB0522200D0/en
Publication of GB2415379A publication Critical patent/GB2415379A/en
Application granted granted Critical
Publication of GB2415379B publication Critical patent/GB2415379B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/09—Lichens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Reproductive Health (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Oncology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
GB0522200A 2003-03-31 2003-03-31 Methyl-ß-orcinolcarboxylate from lichen (everniasrum cirrhatum) for use for the treatment of cancer Expired - Fee Related GB2415379B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB0701454A GB2432530A (en) 2003-03-31 2003-03-31 Methyl-beta-orcinol carboxylate for use in treating fungal infections and antifungal compositions comprising it
GB0716892A GB2438552B (en) 2003-03-31 2003-03-31 Ethanolic extracts from lichen (Everniastrum Cirrhatum) for use for the treatment of fungal infections

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2003/000097 WO2004087128A1 (en) 2003-03-31 2003-03-31 Methyl-β-orcinolcarboxylate from lichen (everniastrum cirrhatum) for use for the treatment of fungal infections and cancer

Publications (3)

Publication Number Publication Date
GB0522200D0 GB0522200D0 (en) 2005-12-07
GB2415379A GB2415379A (en) 2005-12-28
GB2415379B true GB2415379B (en) 2007-10-31

Family

ID=33104946

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0522200A Expired - Fee Related GB2415379B (en) 2003-03-31 2003-03-31 Methyl-ß-orcinolcarboxylate from lichen (everniasrum cirrhatum) for use for the treatment of cancer

Country Status (6)

Country Link
JP (1) JP4498930B2 (en)
AU (1) AU2003226628A1 (en)
CA (1) CA2521055A1 (en)
DE (1) DE10394214T5 (en)
GB (1) GB2415379B (en)
WO (1) WO2004087128A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006137172A1 (en) * 2005-06-24 2006-12-28 Taiyo Kagaku Co., Ltd. Pest control agent of fungi or parasites for fish
JP2010202562A (en) * 2009-03-03 2010-09-16 Ogawa & Co Ltd Phenol-based antimicrobial agent
JP2023542464A (en) * 2020-07-27 2023-10-10 ズー ファーマ ダイナミクス リミテッド ライアビリティ カンパニー Lichen extract-based formulations for cervids

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05271064A (en) * 1991-11-27 1993-10-19 Dainippon Jochugiku Co Ltd Antibacterial agent for methicillin-resistant staphylococcus aureus and infection preventing method using the agent

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05271064A (en) * 1991-11-27 1993-10-19 Dainippon Jochugiku Co Ltd Antibacterial agent for methicillin-resistant staphylococcus aureus and infection preventing method using the agent

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Journal of Medicinal and Aromatic Plant Sciences Vol. 22-23, No. 4A-1A, 2000, pages 169-172 *
Journal of Natural Products Vol. 48, No. 1, 1985, pages 157-158 *
Journal of Natural Products Vol. 49, No. 6, 1986, pages 1159-1160 *

Also Published As

Publication number Publication date
JP4498930B2 (en) 2010-07-07
DE10394214T5 (en) 2006-03-16
AU2003226628A1 (en) 2004-10-25
WO2004087128A1 (en) 2004-10-14
GB2415379A (en) 2005-12-28
JP2006514969A (en) 2006-05-18
GB0522200D0 (en) 2005-12-07
CA2521055A1 (en) 2004-10-14

Similar Documents

Publication Publication Date Title
PL375532A1 (en) Benzimidazol-1-yl-thiophene compounds for the treatment of cancer
EP1613308A4 (en) Novel methods for the treatment of cancer
HK1086488A1 (en) Compound and use thereof for the treatment of cancer
EP1599196A4 (en) Combination therapies for the treatment of cancer
HK1097410A1 (en) Analogs of benzoquinone-containing ansamycins for the treatment of cancer
PL370029A1 (en) 2-amino-4-heteroarylaminopyrimidine derivatives for use in the treatment of cancer
EP1535610A4 (en) Therapeutic agent for cancer
HK1072443A1 (en) Immunoconjugates for the treatment of tumours
HUP0400314A3 (en) Pharmaceutical combinations for the treatment of cancer
AU2003212634A8 (en) Compounds useful in the treatment of cancer
PL377464A1 (en) Aminoalkoxyindoles as 5-ht6-receptor ligands for the treatment of cns-disorders
EP1551388A4 (en) Compounds useful for the treatment of cancer, compositions thereof and methods therewith
IL175689A0 (en) Enoxaparin for the treatment of cancer
HUP0402341A3 (en) Compositions containing thiazol-2-ylamines for the treatment of cancer
AU2003223538A1 (en) Methods for the treatment of cancer
LT1496918T (en) Use of sodium meta-arsenite for the treatment of tumours
AU2003270202A8 (en) Pharmaceutical compositions useful for the treatment of cancers
GB2415379B (en) Methyl-ß-orcinolcarboxylate from lichen (everniasrum cirrhatum) for use for the treatment of cancer
GB0329416D0 (en) Treatment of cancer
EP1684795A4 (en) Methods and agents for the treatment of cancer
AU2003240174A8 (en) Compositions for the treatment of edematous-firbrosclerotic panniculopathy
GB0701454D0 (en) Methyl-B-oreinolcarboxylate from lichen (Everniastrum cirrhatum) for use for the treatment of fungal infections
GB2383538B (en) Cancer treatment
GB0324482D0 (en) Methods for the treatment of cancer
GB0716892D0 (en) Methyl-.-orcinolcarboxylate from lichen (everniastrum cirrhatum) for use for the treatment of fungal infections

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20120331